Tech Company Financing Transactions
Airway Therapeutics Funding Round
Private investors participated in a $15.5 million Series C funding round for Airway Therapeutics. The round was announced on 1/9/2020.
Transaction Overview
Company Name
Announced On
1/9/2020
Transaction Type
Venture Equity
Amount
$15,500,000
Round
Series C
Investors
Proceeds Purpose
This funding will enable clinical development of AT-100 (rhSP-D), an investigational preventive treatment for the serious respiratory disease bronchopulmonary dysplasia (BPD) in very preterm infants, while also supporting preclinical research in influenza, respiratory syncytial virus (RSV) and cystic fibrosis.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11804 Conrey Rd. 175
Cincinnati, OH 45249
USA
Cincinnati, OH 45249
USA
Phone
Website
Email Address
Not Recorded
Overview
Airway Therapeutics was created in 2011 as a spin-out of Cincinnati Children's Hospital Medical Center (CCHMC). Our goal is to bring innovation and expertise in protein therapeutics development for applications in the lung and pediatrics disciplines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Marc Salzberg
Chief Financial Officer
Alan Wolk
Chief Medical Officer
Paul Kingma
Vice President
Paul Remsen
VP - Regulatory Affairs
Uday Patel
Browse more venture capital transactions:
Prev: 1/9/2020: AvePoint venture capital transaction
Next: 1/9/2020: Kiyatec venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs